Axogen, Inc. Capital Expenditures Incurred but Not yet Paid
Axogen, Inc. (AXGN) reported Capital Expenditures Incurred but Not yet Paid of $236.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-10-29
- Axogen, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $104.00K.
- Axogen, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $16.00K.
- Axogen, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $116.00K, a 77.52% decline year-over-year.
- Axogen, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $0.00.
- Axogen, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $114.00K, a 83.81% decline from fiscal 2023.
- Axogen, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $704.00K, a 18.71% decline from fiscal 2022.
- Axogen, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $866.00K, a 39.01% decline from fiscal 2021.
- Axogen, Inc. capital expenditures incurred but not yet paid for fiscal 2021 was $1.42M, a 31.85% increase from fiscal 2020.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $120.00K derived: sum of 2 quarters · filed 2025-10-29 | $236.00K 10-Q · filed 2025-10-29 | $236.00K derived: sum of 4 quarters · filed 2025-10-29 | |
| 2025-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $132.00K 10-Q · filed 2025-08-05 | $132.00K derived: sum of 3 quarters · filed 2025-08-05 | $68.00K derived: sum of 4 quarters · filed 2025-10-29 | |
| 2025-03-31 | $116.00K 10-Q · filed 2025-05-08 | $116.00K derived: sum of 2 quarters · filed 2025-05-08 | $52.00K derived: sum of 3 quarters · filed 2025-10-29 | -$286.00K derived: sum of 4 quarters · filed 2025-10-29 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$64.00K derived: sum of 2 quarters · filed 2025-10-29 | -$402.00K derived: sum of 3 quarters · filed 2025-10-29 | $114.00K 10-K · filed 2025-02-26 | |
| 2024-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$402.00K derived: sum of 2 quarters · filed 2025-10-29 | $114.00K 10-Q · filed 2025-10-29 | -$35.00K derived: sum of 4 quarters · filed 2025-10-29 | |
| 2024-06-30 | -$338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $178.00K 10-Q · filed 2025-08-05 | $29.00K derived: sum of 3 quarters · filed 2025-08-05 | -$936.00K derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | $516.00K 10-Q · filed 2025-05-08 | $367.00K derived: sum of 2 quarters · filed 2025-05-08 | -$598.00K derived: sum of 3 quarters · filed 2025-05-08 | $194.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$1.11M derived: sum of 2 quarters · filed 2025-02-26 | -$322.00K derived: sum of 3 quarters · filed 2025-02-26 | $704.00K 10-K · filed 2025-02-26 | |
| 2023-09-30 | -$965.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$173.00K derived: sum of 2 quarters · filed 2024-11-07 | $853.00K 10-Q · filed 2024-11-07 | -$371.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $792.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.82M 10-Q · filed 2024-08-08 | $594.00K derived: sum of 3 quarters · filed 2025-02-26 | $867.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $1.03M 10-Q · filed 2024-05-02 | -$198.00K derived: sum of 2 quarters · filed 2025-02-26 | $75.00K derived: sum of 3 quarters · filed 2025-02-26 | $773.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$951.00K derived: sum of 2 quarters · filed 2025-02-26 | -$253.00K derived: sum of 3 quarters · filed 2025-02-26 | $866.00K 10-K · filed 2025-02-26 | |
| 2022-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $971.00K derived: sum of 2 quarters · filed 2023-11-07 | $2.09M 10-Q · filed 2023-11-07 | $2.05M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | $698.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.82M 10-Q · filed 2023-08-08 | $1.78M derived: sum of 3 quarters · filed 2024-03-05 | $202.00K derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | $1.12M 10-Q · filed 2023-05-09 | $1.08M derived: sum of 2 quarters · filed 2024-03-05 | -$496.00K derived: sum of 3 quarters · filed 2024-03-05 | -$2.30M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$1.61M derived: sum of 2 quarters · filed 2024-03-05 | -$3.42M derived: sum of 3 quarters · filed 2024-03-05 | $1.42M 10-K · filed 2024-03-05 | |
| 2021-09-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$3.38M derived: sum of 2 quarters · filed 2022-11-08 | $1.46M 10-Q · filed 2022-11-08 | $1.27M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $3.04M 10-Q · filed 2022-08-05 | $2.84M derived: sum of 3 quarters · filed 2023-03-14 | $3.50M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-03-31 | $4.84M 10-Q · filed 2022-05-05 | $4.64M derived: sum of 2 quarters · filed 2023-03-14 | $5.30M derived: sum of 3 quarters · filed 2023-03-14 | $2.24M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2020-12-31 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $460.00K derived: sum of 2 quarters · filed 2023-03-14 | -$2.60M derived: sum of 3 quarters · filed 2023-03-14 | $1.08M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $654.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$2.40M derived: sum of 2 quarters · filed 2021-11-04 | $1.27M 10-Q · filed 2021-11-04 | $3.80M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | -$3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $617.00K 10-Q · filed 2021-08-05 | $3.15M derived: sum of 3 quarters · filed 2022-02-25 | $3.26M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $3.67M 10-Q · filed 2021-05-06 | $6.20M derived: sum of 2 quarters · filed 2022-02-25 | $6.32M derived: sum of 3 quarters · filed 2022-02-25 | $5.94M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $2.65M derived: sum of 2 quarters · filed 2022-02-25 | $2.27M derived: sum of 3 quarters · filed 2022-02-25 | $3.21M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$262.00K derived: sum of 2 quarters · filed 2020-10-30 | $684.00K 10-Q · filed 2020-10-30 | ||
| 2019-06-30 | -$379.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $567.00K 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | $946.00K 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | $335.00K 10-K · filed 2021-03-01 | ||||
| 2017-12-31 | $55.00K 10-K · filed 2020-02-24 | $55.38K 10-K · filed 2018-02-28 | |||
| 2016-12-31 | $32.00K 10-K · filed 2019-02-26 | $32.15K 10-K · filed 2017-03-01 | |||
| 2015-12-31 | $168.78K 10-K · filed 2018-02-28 | ||||
| 2014-12-31 | $22.57K 10-K · filed 2016-02-29 | ||||
| 2013-12-31 | $173.61K 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |